SEC Tracker
Get the app

Stoke Therapeutics STOK

Stoke Therapeutics reports stock sale

Barry Ticho, insider filing for STOK

Form
4
Filed
Importance
Routine
  1. Barry Ticho sold 1,051 shares on Oct 1, 2026
  2. Sold at $26.1594 average price
  3. 19,059 shares remaining after sale
  4. Transaction under Rule 10b5-1 trading plan

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Stoke Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Trevi Therapeutics TRVI public float $588M, Jun 30, 2025
  2. Mersana Therapeutics MRSN
  3. Evolus EOLS public float $560M, Jun 30, 2025
  4. Xencor XNCR public float $556M, Jun 30, 2025
  5. Amphastar Pharmaceuticals AMPH public float $633M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.